Loading clinical trials...
Loading clinical trials...
Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
Conditions
Interventions
STAGE-12
Treatment as Usual
Locations
10
United States
Gateway Community Services
Jacksonville, Florida, United States
Hina Mauka Kaneohe Rehabilitation Services
Kaneohe, Hawaii, United States
Maryhaven, Inc.
Columbus, Ohio, United States
Willamette Family Treatment Services
Eugene, Oregon, United States
ChangePoint, Inc.
Portland, Oregon, United States
Addiction Medicine Services (WPIC)
Pittsburgh, Pennsylvania, United States
Start Date
January 1, 2008
Primary Completion Date
April 1, 2010
Completion Date
April 1, 2010
Last Updated
December 5, 2016
NCT01036581
NCT05877742
NCT05361603
NCT05731999
NCT03612713
NCT05063097
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions